Background Breast anesthesia and hypoesthesia occur commonly after mastectomy and negatively impact quality of life. Neurotization during deep inferior epigastric perforator (DIEP) breast reconstruction offers enhanced sensory recovery. However, access to neurotization for DIEP reconstruction patients has not been evaluated.
Methods This retrospective study included patients who underwent DIEP breast reconstruction between January 2021 and July 2022 at a tertiary-care, academic institution. Demographics, outcomes, insurance type, and Area Deprivation Index (ADI) were compared using two-sample t-test or chi-square analysis.
Results Of the 124 patients who met criteria, 41% had neurotization of their DIEP flaps. There was no difference in history of tobacco use (29% vs 33%), diabetes (14% vs 9.6%), operative time (9.43 vs 9.73 h), length of hospital stay (3 d vs 3 d), hospital readmission (9.8% vs 6.8%), or reoperation (12% vs 12%) between patients with and without neurotization. However, access to neurotization differed significantly by patient health insurance type. Patients who received neurotization had a lower median ADI percentile of 40.0, indicating higher socioeconomic advantage compared with patients who did not receive neurotization at 59.0 (p = 0.01).
Conclusion Access to neurotization differed significantly by patient health insurance and by ADI percentile. Expanding insurance coverage to cover neurotization is needed to increase equitable access and enhance quality of life for patients who come from disadvantaged communities. Our institution's process for preauthorization is outlined to enhance likelihood of insurance approval for neurotization.
Keywords breast reconstruction - deep inferior epigastric perforator - DIEP - autologous reconstruction Financial Disclosure StatementDr. Risal Djohan is a member for Axogen speakers and advisory group. None of the other authors has a financial interest, commercial association, or disclosure regarding any of the companies, organizations, products, services, devices, or drugs that may be mentioned in this manuscript. There are no funding sources to disclose, including NIH, Wellcome Trust, HHMI, or other.
American Society of Plastic Surgeons Annual Meeting in Austin, TX (10/2023).
Publication HistoryReceived: 31 May 2024
Accepted: 12 August 2024
Accepted Manuscript online:
27 August 2024
Article published online:
20 September 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
留言 (0)